SESSION TITLE: Education, Research, and Quality Improvement Posters SESSION TYPE: Original Investigation Posters PRESENTED ON: October 18-21, 2020 PURPOSE: Although chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality in the United States, a majority of COPD patients are not diagnosed. Spirometry remains the “gold standard” for COPD diagnosis; however, it is not recommended for screening and not widely available. The CAPTURE (COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk) study is validating a simple case finding tool consisting of five questions, and peak flow in selected individuals, to find undiagnosed patients with clinically significant COPD in primary care. Education was provided to healthcare providers to increase knowledge related to the identification and management of COPD in diverse primary care practices in six Primary Care Based Research Networks and also offered to the general healthcare provider community through an online distribution platform. This abstract reports the effectiveness of the education. METHODS: Live and online certified continuing education was developed to support the educational needs of primary care teams. Required live sessions for CAPTURE study primary care practices featured team viewing of COPD 101: Basic Diagnosis and Management followed by a virtual discussion with study investigators. All clinic sites completed a pre-test to gauge baseline knowledge of COPD prior to the education and a post-test to assess learning after the education. RESULTS: From September 2018 to January 2020, 616 CAPTURE study healthcare professionals participated in 62 live educational sessions. Significant learning gains were noted across all sites with an aggregate relative knowledge gain of 38%, and an aggregate effect size of 0.61 representing a moderate effect. Similarly, the online module available publicly (N=267) resulted in a 47% overall relative knowledge gain and aggregate effect size of 0.61 representing a moderate effect. Both live and online education demonstrated learning gains for each of the study objectives with significant increases in knowledge related to application of updated clinical practice guidelines to the diagnosis and management of patients with COPD (Figure 1). In addition to measuring knowledge, providers were asked to fill out an evaluation that measured satisfaction and intent to change. Of those that completed the evaluation (N=250, live; N=234, online), 97% reported the education met their educational needs and reinforced/improved their current skills. Ninety-five percent indicated that they intended to make changes to their practice as a result of the education. CONCLUSIONS: This study indicates that targeted COPD education provided online and in live sessions for primary care teams improved knowledge, skills and intent to change practice by employing evidence-based recommendations to appropriately diagnose and manage patients with COPD. CLINICAL IMPLICATIONS: Education to primary care can improve care of COPD. DISCLOSURES: no disclosure on file for Bruce Bender; No relevant relationships by Rowena Dolor, source=Web Response No relevant relationships by Nancy Elder, source=Web Response Consultant relationship with BI Please note: $20001 - $100000 Added 04/02/2020 by MeiLan Han, source=Web Response, value=Consulting fee Consultant relationship with AstraZenea Please note: $20001 - $100000 Added 04/02/2020 by MeiLan Han, source=Web Response, value=Consulting fee Consultant relationship with Merck Please note: $1001 - $5000 Added 04/02/2020 by MeiLan Han, source=Web Response, value=Consulting research support relationship with Novartis Please note: >$100000 Added 04/02/2020 by MeiLan Han, source=Web Response, value=Provided drug clin trial Consultant relationship with GSK Please note: $20001 - $100000 Added 05/28/2020 by MeiLan Han, source=Web Response, value=Consulting fee Consultant relationship with BI Please note: $5001 - $20000 Added 05/28/2020 by MeiLan Han, source=Web Response, value=Consulting fee Consultant relationship with AZ Please note: $20001 - $100000 Added 05/28/2020 by MeiLan Han, source=Web Response, value=Consulting fee Consultant relationship with Mylan Please note: $1001 - $5000 Added 05/28/2020 by MeiLan Han, source=Web Response, value=Consulting fee Consultant relationship with Merck Please note: $1001 - $5000 Added 05/28/2020 by MeiLan Han, source=Web Response, value=Consulting fee Research support relationship with Novartis Please note: >$100000 Added 05/28/2020 by MeiLan Han, source=Web Response, value=Grant/Research Research support relationship with Sunovion Please note: >$100000 Added 05/28/2020 by MeiLan Han, source=Web Response, value=Grant/Research Support No relevant relationships by Min Joo, source=Web Response no disclosure on file for Lyndee Knox; Advisory Committee Member relationship with Astra Zeneca Please note: $1001 - $5000 Added 04/29/2020 by Barry Make, source=Web Response, value=Travel DSMB relationship with Spiration Please note: $1001 - $5000 Added 04/29/2020 by Barry Make, source=Web Response, value=Travel Advisory Committee Member relationship with GlaxoSmithKline Please note: $1001 - $5000 Added 04/29/2020 by Barry Make, source=Web Response, value=Travel Advisory Committee Member relationship with Sunovion Please note: $1001 - $5000 Added 04/29/2020 by Barry Make, source=Web Response, value=Travel PI relationship with Pearl Please note: $5001 - $20000 Added 04/29/2020 by Barry Make, source=Web Response, value=Grant/Research Support Advisory Committee Member relationship with Circsssia Please note: $1-$1000 Added 04/29/2020 by Barry Make, source=Web Response, value=Travel Advisory Committee Member relationship with Third Pole Please note: $1-$1000 Added 04/29/2020 by Barry Make, source=Web Response, value=Travel Advisory Committee Member relationship with Shire Please note: $1-$1000 Added 04/29/2020 by Barry Make, source=Web Response, value=Travel Advisory Committee Member relationship with Phillips Please note: $1-$1000 Added 04/29/2020 by Barry Make, source=Web Response, value=Travel PI relationship with NHLBI Please note: >$100000 Added 04/29/2020 by Barry Make, source=Web Response, value=Grant/Research Support DSMB relationship with Takeda Please note: $1-$1000 Added 04/29/2020 by Barry Make, source=Web Response, value=Travel Advisory Committee Member relationship with Wolters Kluwer Health Please note: $1-$1000 Added 04/29/2020 by Barry Make, source=Web Response, value=Travel Removed 04/29/2020 by Barry Make, source=Web Response Scientific Medical Advisor relationship with AstraZeneca Please note: $1001 - $5000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Consulting fee Advisory Committee Member relationship with Astra Zeneca Please note: $5001 - $20000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Travel IPF Steering Committee relationship with Bayer Please note: $1-$1000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Grant/Research Scientific Medical Advisor relationship with Boehringer Ingelheim Please note: $1001 - $5000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Consulting fee Scientific Medical Advisor relationship with Boehringer Ingelheim Please note: $5001 - $20000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Travel Scientific Medical Advisor relationship with ProTerrix Bio Please note: $1-$1000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Intellectual property rights Scientific Medical Advisor relationship with CSL Behring Please note: $1001 - $5000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Consulting fee Scientific Medical Advisor relationship with CSL Behring Please note: $1001 - $5000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Travel Scientific Medical Advisor relationship with Genentech Please note: $1001 - $5000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Consulting fee Scientific Medical Advisor relationship with Genentech Please note: $5001 - $20000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Travel Scientific Medical Advisor relationship with GlaxoSmithKline Please note: $20001 - $100000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Consulting fee Scientific Medical Advisor relationship with GlaxoSmithKline Please note: $5001 - $20000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Travel Scientific Medical Advisor relationship with Respivant Please note: $5001 - $20000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Consulting fee Speaker/Speaker's Bureau relationship with Respivant Please note: $5001 - $20000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Travel Scientific Medical Advisor relationship with ProMedior/Roche Please note: $5001 - $20000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Consulting fee Scientific Medical Advisor relationship with Sanofi/Regeneron Please note: $1001 - $5000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Consulting fee Scientific Medical Advisor relationship with Sanofi/Regeneron Please note: $1-$1000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Travel Scientific Medical Advisor relationship with twoXR Please note: $1-$1000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Advisor Scientific Medical Advisor relationship with Veracyte Please note: $1-$1000 Added 05/20/2020 by Fernando Martinez, source=Web Response, value=Intellectual property rights No relevant relationships by Catherine Meldrum, source=Web Response No relevant relationships by Lauren Rieck, source=Web Response scientist on grant relationship with gilead sciences Please note: >$100000 Added 04/02/2020 by Hazel Tapp, source=Web Response, value=Grant/Research Support Consultant relationship with GSK Please note: $5001 - $20000 Added 03/02/2020 by Barbara Yawn, source=Web Response, value=Consulting fee Advisory Committee Member relationship with BI Please note: $1001 - $5000 Added 03/02/2020 by Barbara Yawn, source=Web Response, value=Honoraria Advisory Committee Member relationship with AZ Please note: $1001 - $5000 Added 03/02/2020 by Barbara Yawn, source=Web Response, value=Honoraria Advisory Committee Member relationship with Sunovian Please note: $1001 - $5000 Added 03/02/2020 by Barbara Yawn, source=Web Response, value=Honoraria